US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors By Reuters
US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors…
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
Astrazeneca: Wichtiges Medikament erreicht Ziele in Lungenkrebsstudie
CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat in einer abschließenden klinischen Studie (Phase-III) mit Lungenkrebs-Patienten einen Erfolg erzielt. Das…
Imfinzi improved OS & PFS in limited-stage SCLC
05 April 2024
Imfinzi significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase…
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
FDA approves AstraZenecas (AZN) Voydeya (danicopan) in the United States as add on therapy to its other C5 inhibitors. Merck…
AstraZenecas (AZN) Imfinzi Improves Survival in SCLC Study
AstraZenecas (AZN) Imfinzi improves overall survival and progression-free survival for patients with limited-stage small cell lung cancer in the phase…